Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
Plos One|April 22, 2016
Validation and Application of a Custom-Designed Targeted Next-Generation Sequencing Panel for the Diagnostic Mutational Profiling of Solid TumorsGuy Froyen, An Broekmans, Femke Hillen, et al.
Virchows Archiv : an International Journal of Pathology|September 21, 2023
Novel gene fusion discovery in Spitz tumours and its relevance in diagnosticsLouis Delsupehe, Thomas Steelandt, Julie Lemahieu, et al.
Biosensors & Bioelectronics|April 11, 2025
Hybridization-based sensor with large dynamic range for detection of circulating tumor DNA in clinical samplesYannick Stulens, Rebekka Van Hoof, Karen Hollanders, et al.
Clinical Chemistry and Laboratory Medicine|September 18, 2025
EFLM checklist for the assessment of AI/ML studies in laboratory medicine: enhancing general medical AI frameworks for laboratory-specific applicationsAnna Carobene, Janne Cadamuro, Glynis Frans, et al.
American Journal of Clinical Pathology|November 1, 2021
Cycle Threshold Probability Score for Immediate and Sensitive Detection of B.1.351 SARS-CoV-2 LineageDieter De Smet, Merijn Vanhee, Brigitte Maes, et al.
Blood|October 24, 2002
Frequent occurrence of BCL6 rearrangements in nodular lymphocyte predominance Hodgkin lymphoma but not in classical Hodgkin lymphomaIwona Wlodarska, Peet Nooyen, Brigitte Maes, et al.
International Journal of Molecular Sciences|April 30, 2021
A Potential Role for Fructosamine-3-Kinase in Cataract TreatmentSander De Bruyne, Loes van Schie, Jonas Himpe, et al.
Biopreservation and Biobanking|November 10, 2018
Archival May-Grünwald-Giemsa-Stained Bone Marrow Smears Are an Eligible Source for Molecular DNA ResearchBénedith Oben, Charlotte Cosemans, Ingrid Arijs, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 7, 2018
Prognostic Biomarkers in the Progression From MGUS to Multiple Myeloma: A Systematic ReviewCharlotte Cosemans, Bénedith Oben, Ingrid Arijs, et al.
Genes, Chromosomes & Cancer|July 12, 2002
Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumorJan Cools, Iwona Wlodarska, Riet Somers, et al.
Pageof 8